PPARGC1A and hydrops fetalis: Using a combination of gain-of-function (GOF) experiments in mice and cultured cardiomyocytes, we demonstrate that miR-22 directly inhibits PGC-1α, PPARα, and SIRT1 expression levels leading to HF.